• 1. Successive C1–C2 bond cleavage: the mechanism of vanadium(v)-catalyzed aerobic oxidation of d-glucose to formic acid in aqueous solution
  Muge Niu,Yucui Hou,Weize Wu,Shuhang Ren,Ru Yang Phys. Chem. Chem. Phys. 2018 20 17942
• 2. Catalytic conversion of glucose into alkanediols over nickel-based catalysts: a mechanism study
  Zhichao Tan,Gai Miao,Chang Liu,Hu Luo,Liwei Bao,Lingzhao Kong,Yuhan Sun RSC Adv. 2016 6 62747
• 3. A method for the measurement of lactate, glycerol and fatty acid production from 14C-glucose in primary cultures of rat epididymal adipocytes
  Ana Cecilia Ho-Palma,Floriana Rotondo,María del Mar Romero,Serena Memmolo,Xavier Remesar,José Antonio Fernández-López,Marià Alemany Anal. Methods 2016 8 7873
• 4. Tuning of MgO's base characteristics by blending it with amphoteric ZnO facilitating the selective glucose isomerization to fructose for bioenergy development
  Sangeeta Mahala,Senthil M. Arumugam,Sandeep Kumar,Bhawana Devi,Sasikumar Elumalai Nanoscale Adv. 2023 5 2470
• 5. Bacterial sterol surrogates. Biosynthesis of the side-chain of bacteriohopanetetrol and of a carbocyclic pseudopentose from 13C-labelled glucose in Zymomonas mobilis
  Michel Rohmer,Bertrand Sutter,Hermann Sahm J. Chem. Soc. Chem. Commun. 1989 1471

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Monosaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Monosaccharides

Research Brief on 105931-74-6 and D-Glucose-2-13C: Advances in Chemical Biology and Pharmaceutical Applications

The chemical compound 105931-74-6 and the isotopically labeled glucose derivative D-Glucose-2-13C have garnered significant attention in recent research within the chemical biology and pharmaceutical sectors. These compounds play pivotal roles in metabolic studies, drug development, and diagnostic applications. This research brief synthesizes the latest findings and advancements related to these key substances, providing insights into their applications and implications for future research.

105931-74-6, a compound with specific pharmacological properties, has been investigated for its potential in modulating metabolic pathways. Recent studies highlight its role in targeting enzymes involved in glycolysis and oxidative phosphorylation, making it a candidate for therapeutic interventions in metabolic disorders. Concurrently, D-Glucose-2-13C, a stable isotope-labeled glucose, is extensively utilized in metabolic flux analysis (MFA) to trace carbon flow in biological systems. Its application in cancer research, particularly in understanding the Warburg effect, has provided novel insights into tumor metabolism.

In a 2023 study published in the Journal of Chemical Biology, researchers employed D-Glucose-2-13C to elucidate the metabolic reprogramming in cancer cells. The study demonstrated that the incorporation of 13C-labeled glucose into metabolic intermediates could be quantified using advanced mass spectrometry techniques, offering a precise method to map metabolic networks. This approach has significant implications for developing targeted therapies that disrupt cancer cell metabolism.

Another groundbreaking research effort focused on 105931-74-6 explored its interaction with mitochondrial enzymes. Findings revealed that the compound exhibits inhibitory effects on specific dehydrogenases, thereby altering cellular energy production. These results, published in the European Journal of Medicinal Chemistry, suggest potential applications in treating diseases characterized by mitochondrial dysfunction, such as neurodegenerative disorders and diabetes.

The synergy between 105931-74-6 and D-Glucose-2-13C is also being investigated in preclinical models. For instance, a recent collaborative study between academic and industry researchers utilized both compounds to study metabolic adaptations in drug-resistant bacterial strains. The integration of isotopic tracing with pharmacological inhibition provided a comprehensive understanding of bacterial metabolism under stress conditions, paving the way for novel antibiotic development.

Looking ahead, the continued exploration of 105931-74-6 and D-Glucose-2-13C holds promise for advancing both basic and applied research. Future directions may include the development of more potent derivatives of 105931-74-6 with enhanced selectivity and the application of D-Glucose-2-13C in clinical diagnostics. As these compounds become more integral to research and therapeutic strategies, their impact on chemical biology and pharmaceutical sciences is expected to grow exponentially.

• 2033-24-1(2,2-dimethyl-1,3-dioxane-4,6-dione)
• 9002-18-0(Agar)
• 58-86-6(D(+)-Xylose)
• 4618-18-2(Lactulose)
• 97-30-3(Methyl a-D-Glucopyranoside)
• 6155-35-7(α-L-Rhamnose monohydrate)
• 7660-25-5(Fructose)
• 641-74-7((3R,3aR,6R,6aR)-hexahydrofuro[3,2-b]furan-3,6-diol)
• 63-42-3(Lactose)
• 585-88-6(Maltitol)